Category: Blog articles

MIG Capital co-leads €63 million Series A round for autoimmune biotech SciRhom

Posted on by Laura Pivac-Bieser

MIG Capital AG

  • Ismaninger Straße 102
  • D-81675 Munich
  • Germany
Linkedin-in Twitter
Media
About Us
Portfolio
We love to support:
Non-profit Engagement
  • Back To Top